glp 1 and sglt2 GLP-1 Receptor Agonist Therapy With Without Inhibitors in Patients With Type 2 Diabetes SGLT2 vs GLP-1 for CKD:

The grace period for tirzepatide manufacturers is over, and semaglutide producers have until Tuesday or May 22, depending on whether theyre a state-licensed pharmacy or an outsourcing facility

The Double Mechanism of Risk Increased Ketogenesis from Lower Insulin When insulin levels drop: Fat breakdown increases Free fatty acids are converted to ketones in the liver Blood ketone levels rise Even if glucose levels are normal or mildly elevated, ketone accumulation can lead to metabolic acidosis

A potential mechanism of receptor resensitization

However, its essential to understand that period changes are not officially listed as side effects but do occur anecdotally